Code details & principles for
Code | Description | Chapter/Sub-Chapter | Code Specific Guidance |
---|---|---|---|
BT260 | Planning for insertion and removal of radioactive agent (brachytherapy) into carcinoma of the oesophagus, bronchus or stomach | 11.1.0 Oesophagus, 20.0.0 Radiotherapy, 8.1.0 Oesophagus |
CCSD Code (unacceptable combination) | Narrative (unacceptable combination) | Date Added |
---|---|---|
BT270 | Insertion and removal of radioactive agent (brachytherapy) into carcinoma of the oesophagus, bronchus or stomach | 2013-10-23 |
E4990 | Panendoscopy +/- incisional biopsy | 2013-03-03 |
E4991 | Therapeutic Panendoscopy +/- excision biopsy, excision or destruction of lesions | 2011-10-18 |
G4410 | Therapeutic oesophago-gastro-duodenoscopy (OGD) with insertion of prosthesis | 2014-08-06 |
G4430 | Therapeutic oesophago-gastro-duodenoscopy (OGD) with dilatation | 2011-09-05 |
G6500 | Diagnostic oesophago-gastro-duodenoscopy (OGD) includes forceps biopsy, biopsy urease test and dye spray | 2014-04-25 |
These coding principles set out how the authors intend that the codes and narratives within the CCSD Schedule are interpreted and used. The outputs are available to be used by all individual insurers and providers including CCSD and non-CCSD members. Please note that: